咨询与建议

限定检索结果

文献类型

  • 1 篇 期刊文献

馆藏范围

  • 1 篇 电子文献
  • 0 种 纸本馆藏

日期分布

学科分类号

  • 1 篇 医学
    • 1 篇 临床医学
    • 1 篇 药学(可授医学、理...

主题

  • 1 篇 daphnane diterpe...
  • 1 篇 crpc
  • 1 篇 cancer
  • 1 篇 drug discovery
  • 1 篇 natural product
  • 1 篇 nuclear transpor...
  • 1 篇 enzalutamide-res...
  • 1 篇 importin-β1

机构

  • 1 篇 school of pharma...
  • 1 篇 school of medici...
  • 1 篇 school of pharma...

作者

  • 1 篇 junjian wang
  • 1 篇 gui-hua tang
  • 1 篇 fang-yu yuan
  • 1 篇 jia-luo huang
  • 1 篇 dong huang
  • 1 篇 huahua gao
  • 1 篇 sheng yin
  • 1 篇 shen li
  • 1 篇 lu gan
  • 1 篇 xue-long yan
  • 1 篇 run-zhu fan
  • 1 篇 hong-wu chen
  • 1 篇 xinying zhu

语言

  • 1 篇 英文
检索条件"主题词=Enzalutamide-resistance"
1 条 记 录,以下是1-10 订阅
排序:
Discovery of a highly potent and orally available importin-β1 inhibitor that overcomes enzalutamide-resistance in advanced prostate cancer
收藏 引用
Acta Pharmaceutica Sinica B 2023年 第12期13卷 4934-4944页
作者: Jia-Luo Huang Xue-Long Yan Dong Huang Lu Gan Huahua Gao Run-Zhu Fan Shen Li Fang-Yu Yuan Xinying Zhu Gui-Hua Tang Hong-Wu Chen Junjian Wang Sheng Yin School of Pharmaceutical Sciences Sun Yat-sen UniversityGuangzhou 510006China School of Pharmacy Guizhou Medical UniversityGuian New DistrictGuizhou 550025China School of Medicine University of California DavisSacramentoCA 95817USA
Nuclear transporter importin-β1 is emerging as an attractive target by virtue of its prevalence in many ***,the lack of druggable inhibitors restricts its therapeutic proof of *** the present work,we optimized a natu... 详细信息
来源: 维普期刊数据库 维普期刊数据库 同方期刊数据库 同方期刊数据库 评论